跳至主要内容
临床试验/CTRI/2020/03/024325
CTRI/2020/03/024325进行中(未招募)未知

evaluation of efficacy and safety of Ulipristal actate in the management of symptomatic uterine fibroids

sangam jha0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Reproductive and premenopausal women (18-50 years age group)
  • Symptomatic fibroid (heavy menstrual bleed, pain abdomen, pressure symptoms and infertility)
  • Uterine fibroids >=1 in number and size of >= 2cm and <= 10cm on pelvic ultrasound

排除标准

  • Patients refusing medical management
  • Patients with HMB due to causes other than fibroids
  • Patients with clinical jaundice or deranged liver function tests

研究者

发起方
sangam jha

相似试验